ASND
Ascendis Pharma A/S ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$225.98
-3.03 ▼ -1.32%
🌙 3월 13일 4:48 PM ET (한국 3/14 05:48)
$224.00
-1.98 ▼ -0.88%
| Index | - | P/E | - | EPS (ttm) | -4.2 | Insider Own | 0.9% | Shs Outstand | 0.06B | Perf Week | -6.1% |
| Market Cap | 13.87B | Forward P/E | 18.56 | EPS next Y | 143.68% | Insider Trans | - | Shs Float | 0.06B | Perf Month | 2.03% |
| Enterprise Value | 14.17B | PEG | - | EPS next Q | 0.37 | Inst Own | 105.66% | Short Float | 6.36% | Perf Quarter | 12.29% |
| Income | -0.25B | P/S | 16.85 | EPS this Y | 215.38% | Inst Trans | 1.41% | Short Ratio | 5.41 | Perf Half Y | 14.32% |
| Sales | 0.82B | P/B | - | EPS next 5Y | - | ROA | -18.46% | Short Interest | 3.87M | Perf YTD | 5.97% |
| Book/sh | -3.12 | P/C | 19.17 | EPS past 3/5Y | 27.03% 14.76% | ROE | - | 52W High | -9.1% ($248.60) | Perf Year | 48.37% |
| Cash/sh | 11.79 | P/FCF | 269.59 | Sales past 3/5Y | 147.23% 152.45% | ROIC | -97.22% | 52W Low | 82.15% ($124.06) | Perf 3Y | 109.92% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 41.16% | Gross Margin | 84.81% | Volatility(W/M) | 4.27% 4.41% | Perf 5Y | 51.41% |
| Dividend TTM | - | EV/Sales | 17.22 | Sales Y/Y TTM | 110.04% | Oper. Margin | -17.66% | ATR (14) | 10 | Perf 10Y | 1143.01% |
| Dividend Ex-Date | - | Quick Ratio | 0.76 | EPS Q/Q | 7.19% | Profit Margin | -30.85% | RSI (14) | 45.97 | Recom | 1.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.04 | Sales Q/Q | 55.28% | SMA20 | -2.72% ($232.3) | Beta | 0.49 | Target Price | $285.45 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | 0.74% ($224.32) | Rel Volume | 0.85 | Prev Close | $229.01 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | -583.16% 0.79% | SMA200 | 12.65% ($200.6) | Avg Volume(3M) | 0.72M | Price | $225.98 |
| IPO | 2015/1/28 | Option/Short | Yes/Yes | Trades | 8180 | Volume | 606,042 | Change | -1.32% |
뉴스 로딩 중...